New diabetes clinical trial: A Phase 2, Randomized, Placebo Controlled Study Investigating the Efficacy and Safety of Sorafenib in New-Onset Type 1 Diabetes Mellitus

Published on: January 25, 2024 at 11:00PM
Conditions: Type 1 Diabetes
Interventions: Drug: Sorafenib; Drug: Placebo
Sponsors: Second Xiangya Hospital of Central South University
Not yet recruiting
https://ift.tt/kizKr1V